Australia Precision Genomics Market Size, Share, Trends and Forecast to 2035 | AI, NGS, and Public Funding Fuel 13.2% CAGR and a US$1.01 Billion Opportunity
Dublin, Sept. 29, 2026 (GLOBE NEWSWIRE) -- "Australia Precision Genomics Market by Technology, Product & Service, Application, and End User - Trends and Forecasts Till 2035" has been added to ResearchAndMarkets.com's offering.
The Australia precision genomics market is valued at USD 0.33 billion in 2026 and is projected to reach USD 1.01 billion by 2035, expanding at a CAGR of 13.2% during the forecast period. Market growth is being supported by government investment, declining sequencing costs, wider clinical adoption, artificial intelligence integration, and rising demand for genomic testing in oncology, reproductive health, and rare and inherited genetic disorders.
Genomic sequencing is increasingly being incorporated into diagnostic pathways across Australian hospitals, pathology providers, research institutions, and fertility clinics. Oncology remains the leading clinical application, with tumor genomic profiling used to support targeted treatment selection, monitor therapeutic response, and detect recurrence. Rare-disease diagnosis is another important growth area, as genomic testing can accelerate the identification of inherited conditions.
Market Growth Drivers and Emerging Trends
Government-backed initiatives continue to shape the Australia precision genomics market. The Genomics Health Futures Mission, supported through the Medical Research Future Fund, is committing AUD 500.1 million over ten years to advance genomic medicine for more than 200,000 Australians. Funding supports clinical trials, genomic reference datasets, workforce development, and the integration of testing into routine healthcare.
A further AUD 57 million in federal investment is focused on artificial intelligence and genomics. AI-enabled platforms are improving variant interpretation, mutation pattern recognition, clinical decision support, and the analysis of large sequencing datasets. These capabilities can improve diagnostic accuracy and help healthcare providers translate genomic findings into clinical decisions more efficiently.
Direct-to-consumer (DTC) genetic testing is among the fastest-growing precision diagnostics categories in Australia. Demand is being driven by consumer interest in ancestry, wellness, inherited risk, and at-home sample collection. Whole genome sequencing and whole exome sequencing are also gaining adoption for complex diagnostic cases as sequencing costs decline and bioinformatics capabilities improve.
Investment in high-throughput sequencing infrastructure is strengthening national capacity. Facilities such as the Australian Genome Research Facility are deploying advanced platforms, including NovaSeq X Plus systems. Public-private collaboration among hospitals, universities, research organizations, diagnostic laboratories, and biotechnology companies is also accelerating technology adoption and commercialization.
Challenges Affecting Precision Genomics Adoption
Market expansion continues to face several barriers. Advanced sequencing instruments and comprehensive genomic panels require substantial investment, while reimbursement remains inconsistent for many tests. Australia also faces shortages of clinical geneticists, bioinformatics specialists, and genetic counsellors, limiting the healthcare system's ability to interpret results at scale.
Genomic data privacy, secondary data use, cybersecurity, and interoperability between pathology and hospital IT systems remain important concerns. Diagnostic accuracy may also be affected by limited representation of Indigenous and culturally diverse populations in genomic reference datasets. Expanding representative datasets and establishing appropriate data governance frameworks will be essential to equitable market development.
Access outside major metropolitan areas remains uneven, although telehealth-enabled genetic counselling and mobile sample-collection services are improving availability in regional and remote communities.
Australia Precision Genomics Market Segmentation
Key Segment Insights
Next-Generation Sequencing represents the largest technology segment due to its capacity to produce comprehensive genomic data at declining per-base costs. Adoption of whole genome and whole exome sequencing, combined with investment in high-throughput platforms, is expected to sustain the segment's leadership through 2035.
Oncology accounts for the largest share of precision genomic testing volumes in Australia. Continued development of genomically-matched cancer treatments is expected to reinforce demand for tumor profiling and associated molecular diagnostics.
Hospitals and diagnostic laboratories represent the leading end-user category, supported by established molecular pathology infrastructure, multidisciplinary cancer and genetics clinics, and clinician familiarity with genomic testing. New South Wales and Victoria lead the regional market because of their concentration of tertiary hospitals, research universities, pathology networks, and sequencing facilities.
Companies Active in the Australia Precision Genomics Market
Australia Precision Genomics Market Report Coverage
The report provides market sizing and opportunity analysis across technology, product & service, application, and end-user segments. It examines the competitive landscape for sequencing, microarray, PCR-based platforms, reagents, instruments, analytics, and bioinformatics services. Company profiles cover portfolios, strategic initiatives, market positioning, partnerships, product launches, funding activity, and infrastructure investments.
Regulatory and reimbursement analysis addresses Medicare Benefits Schedule coverage, Therapeutic Goods Administration pathways, and state-level factors influencing genomic test adoption. The report also evaluates market drivers, restraints, emerging opportunities, regional access gaps, and the impact of artificial intelligence on genomic diagnostics.
Reasons to Buy the Report
Additional Benefits
Key Topics Covered
1. PREFACE
1.1. Introduction
1.2. Market Share Insights
1.3. Key Market Insights
1.4. Report Coverage
1.5. Key Questions Answered
1.6. Chapter Outlines
2. RESEARCH METHODOLOGY
2.1. Research Assumptions
2.2. Database Building
2.2.1. Data Collection
2.2.2. Data Validation
2.2.3. Data Analysis
2.3. Project Methodology
2.3.1. Secondary Research
2.3.1.1. Annual Reports
2.3.1.2. Academic Research Papers
2.3.1.3. Company Websites
2.3.1.4. Investor Presentations
2.3.1.5. Regulatory Filings
2.3.1.6. White Papers
2.3.1.7. Industry Publications
2.3.1.8. Conferences and Seminars
2.3.1.9. Government Portals
2.3.1.10. Media and Press Releases
2.3.1.11. Newsletters
2.3.1.12. Industry Databases
2.3.1.13. Roots Proprietary Databases
2.3.1.14. Paid Databases and Sources
2.3.1.15. Social Media Portals
2.3.1.16. Other Secondary Sources
2.3.2. Primary Research
2.3.2.1. Introduction
2.3.2.2. Types
2.3.2.2.1. Qualitative
2.3.2.2.2. Quantitative
2.3.2.3. Advantages
2.3.2.4. Techniques
2.3.2.4.1. Interviews
2.3.2.4.2. Surveys
2.3.2.4.3. Focus Groups
2.3.2.4.4. Observational Research
2.3.2.4.5. Social Media Interactions
2.3.2.5. Stakeholders
2.3.2.5.1. Company Executives (CXOs)
2.3.2.5.2. Board of Directors
2.3.2.5.3. Company Presidents and Vice Presidents
2.3.2.5.4. Key Opinion Leaders
2.3.2.5.5. Research and Development Heads
2.3.2.5.6. Technical Experts
2.3.2.5.7. Subject Matter Experts
2.3.2.5.8. Scientists
2.3.2.5.9. Doctors and Other Healthcare Providers
2.3.2.6. Ethics and Integrity
2.3.2.6.1. Research Ethics
2.3.2.6.2. Data Integrity
2.3.3. Analytical Tools and Databases
3. MARKET DYNAMICS
3.1. Forecast Methodology
3.1.1. Top-Down Approach
3.1.2. Bottom-Up Approach
3.1.3. Hybrid Approach
3.2. Market Assessment Framework
3.2.1. Total Addressable Market (TAM)
3.2.2. Serviceable Addressable Market (SAM)
3.2.3. Serviceable Obtainable Market (SOM)
3.2.4. Currently Acquired Market (CAM)
3.3. Forecasting Tools and Techniques
3.3.1. Qualitative Forecasting
3.3.2. Correlation
3.3.3. Regression
3.3.4. Time Series Analysis
3.3.5. Extrapolation
3.3.6. Convergence
3.3.7. Forecast Error Analysis
3.3.8. Data Visualization
3.3.9. Scenario Planning
3.3.10. Sensitivity Analysis
3.4. Key Considerations
3.4.1. Demographics
3.4.2. Market Access
3.4.3. Reimbursement Scenarios
3.4.4. Industry Consolidation
3.5. Robust Quality Control
3.6. Key Market Segmentations
3.7. Limitations
4. MACRO-ECONOMIC INDICATORS
4.1. Time Period
4.1.1. Historical Trends
4.1.2. Current and Forecasted Estimates
4.2. Currency Coverage
4.2.1. Overview of Major Currencies Affecting the Market
4.2.2. Impact of Currency Fluctuations on the Industry
4.3. Foreign Exchange Impact
4.3.1. Evaluation of Foreign Exchange Rates and Their Impact on the Market
4.3.2. Strategies for Mitigating Foreign Exchange Risk
4.4. Recession
4.4.1. Historical Analysis of Past Recessions and Lessons Learnt
4.4.2. Assessment of Current Economic Conditions and Potential Impact on the Market
4.5. Inflation
4.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
4.5.2. Potential Impact of Inflation on Market Evolution
4.6. Interest Rates
4.6.1. Overview of Interest Rates and Their Impact on the Market
4.6.2. Strategies for Managing Interest Rate Risk
4.7. Commodity Flow Analysis
4.7.1. Type of Commodity
4.7.2. Origins and Destinations
4.7.3. Values and Weights
4.7.4. Modes of Transportation
4.8. Global Trade Dynamics
4.8.1. Import Scenario
4.8.2. Export Scenario
4.9. War Impact Analysis
4.9.1. Russian-Ukraine War
4.9.2. Israel-Hamas War
4.10. COVID Impact / Related Factors
4.10.1. Global Economic Impact
4.10.2. Industry-specific Impact
4.10.3. Government Response and Stimulus Measures
4.10.4. Future Outlook and Adaptation Strategies
4.11. Other Indicators
4.11.1. Fiscal Policy
4.11.2. Consumer Spending
4.11.3. Gross Domestic Product (GDP)
4.11.4. Employment
4.11.5. Taxes
4.11.6. R&D Innovation
4.11.7. Stock Market Performance
4.11.8. Supply Chain
4.11.9. Cross-Border Dynamics
5. EXECUTIVE SUMMARY
6. INTRODUCTION
6.1. Overview of Australia Precision Genomics
6.1.1. Key Characteristics of Australia Precision Genomics
6.1.2. Key Applications of Australia Precision Genomics
6.1.3. Challenges Associated with Australia Precision Genomics
6.2. Future Perspective
7. REGULATORY SCENARIO
8. COMPREHENSIVE DATABASE OF LEADING PLAYERS
9. COMPETITIVE LANDSCAPE
9.1. Australia Precision Genomics: Overall Market Landscape
9.1.1. Analysis by Year of Establishment
9.1.2. Analysis by Company Size
9.1.3. Analysis by Location of Headquarters
9.2. Market Segmentation Analysis
9.2.1. Analysis by Type of Technology
9.2.2. Analysis by Type of Product & Service
9.2.3. Analysis by Application
9.2.4. Analysis by End User
9.2.5. Analysis by State
10. COMPANY COMPETITIVENESS ANALYSIS
10.1. Assumptions and Key Parameters
10.2. Methodology
10.3. Overview of Australia-based Peer Groups
11. COMPANY PROFILES
11.1. 10x Genomics
11.1.1. Company Overview
11.1.2. Company Mission
11.1.3. Company Footprint
11.1.4. Management Team
11.1.5. Contact Details
11.1.6. Financial Performance
11.1.7. Operating Business Segments
11.1.8. Product Portfolio
11.1.9. MOAT Analysis
11.1.10. Recent Developments and Future Outlook
11.2. Australian Genome Research Facility (AGRF)
11.3. Australian Clinical Labs / Sonic Genetics
11.4. Agilent Technologies
11.5. BGI Genomics
11.6. Illumina
11.7. Oxford Nanopore Technologies
11.8. Pacific Biosciences
11.9. QIAGEN
11.10. Revvity (Formerly PerkinElmer)
11.11. Roche Diagnostics
11.12. Thermo Fisher Scientific
12. PARTNERSHIPS AND COLLABORATIONS
12.1. Partnership Models
12.2. Australia Precision Genomics: Partnerships and Collaborations
12.2.1. Analysis by Year of Partnership
12.2.2. Analysis by Type of Partnership
12.2.3. Analysis by Year and Type of Partnership
12.2.4. Analysis by Type of Partner
12.2.5. Analysis by Type of Partnership and Type of Partner
12.2.6. Most Active Players: Analysis by Number of Partnerships
12.3. Analysis by Region
12.3.1. Local and International Agreements
12.3.2. Intracontinental and Intercontinental Agreements
13. FUNDING AND INVESTMENT ANALYSIS
13.1. Funding Models
13.2. Australia Precision Genomics: Funding and Investment Analysis
13.2.1. Analysis by Year of Funding
13.2.1.1. Cumulative Year-wise Trend of Funding Instances
13.2.1.2. Cumulative Year-wise Trend of Amount Invested
13.2.2. Analysis by Type of Funding
13.2.2.1. Analysis of Funding Instances
13.2.2.2. Analysis of Amount Invested
13.2.3. Analysis by Year and Type of Funding
13.2.4. Analysis of Amount Invested by Year and Type of Funding
13.2.5. Analysis by Region
13.2.6. Most Active Players
13.2.6.1. Analysis by Number of Funding Instances
13.2.6.2. Analysis by Amount Raised
13.2.6.3. Leading Investors: Analysis by Number of Funding Instances
14. MEGA TRENDS
14.1. Australia Precision Genomics: Key Megatrends
15. MARKET IMPACT ANALYSIS
15.1. Market Drivers
15.2. Market Restraints
15.3. Market Opportunities
15.4. Market Challenges
15.5. Conclusion
16. AUSTRALIA PRECISION GENOMICS MARKET
16.1. Key Assumptions and Methodology
16.2. Trend Disruptions Impacting the Market
16.3. Demand Side Trends
16.4. Supply Side Trends
16.5. Australia Precision Genomics Market, Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
16.6. Multivariate Scenario Analysis
16.6.1. Conservative Scenario
16.6.2. Optimistic Scenario
16.7. Investment Feasibility Index
16.8. Revenue Shift Analysis
16.9. Market Movement Analysis
16.10. Penetration-Growth (P-G) Matrix
16.11. Key Market Segmentations
16.12. Data Triangulation and Validation
16.12.1. Secondary Sources
16.12.2. Primary Sources
16.12.3. Statistical Modeling
17. MARKET OPPORTUNITIES BASED ON TYPE OF TECHNOLOGY
17.1. Australia Precision Genomics Market for Next-Generation Sequencing (NGS): Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
17.2. Australia Precision Genomics Market for Microarray: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
17.3. Australia Precision Genomics Market for Polymerase Chain Reaction (PCR) / qPCR: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
17.4. Australia Precision Genomics Market for Sanger Sequencing: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
17.5. Australia Precision Genomics Market for Other Technologies: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
17.5.1. Australia Precision Genomics Market for Mass Spectrometry: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
17.5.2. Australia Precision Genomics Market for In-Situ Hybridization: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
18. MARKET OPPORTUNITIES BASED ON TYPE OF PRODUCT & SERVICE
18.1. Australia Precision Genomics Market for Instruments & Systems: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
18.2. Australia Precision Genomics Market for Consumables & Reagents: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
18.3. Australia Precision Genomics Market for Software, Analytics & Bioinformatics Services: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
19. MARKET OPPORTUNITIES BASED ON APPLICATION
19.1. Australia Precision Genomics Market for Oncology: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
19.2. Australia Precision Genomics Market for Reproductive Health & Non-Invasive Prenatal Testing (NIPT): Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
19.3. Australia Precision Genomics Market for Rare & Inherited Genetic Disorders: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
19.4. Australia Precision Genomics Market for Cardiovascular Disease: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
19.5. Australia Precision Genomics Market for Neurological Disorders: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
19.6. Australia Precision Genomics Market for Pharmacogenomics: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
19.7. Australia Precision Genomics Market for Infectious Disease Genomics: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
19.8. Australia Precision Genomics Market for Other Applications: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
20. MARKET OPPORTUNITIES BASED ON END USER
20.1. Australia Precision Genomics Market for Hospitals & Diagnostic Laboratories: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
20.2. Australia Precision Genomics Market for Research & Academic Institutes: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
20.3. Australia Precision Genomics Market for Direct-to-Consumer (DTC) Channel: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
20.4. Australia Precision Genomics Market for Pharmaceutical & Biotechnology Companies: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
21. MARKET OPPORTUNITIES BASED ON STATE / REGION
21.1. Australia Precision Genomics Market in New South Wales: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
21.2. Australia Precision Genomics Market in Victoria: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
21.3. Australia Precision Genomics Market in Queensland: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
21.4. Australia Precision Genomics Market in Western Australia: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
21.5. Australia Precision Genomics Market in South Australia: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
21.6. Australia Precision Genomics Market in Rest of Australia: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
22. KEY WINNING STRATEGIES
23. STRATEGIC RECOMMENDATIONS
24. INSIGHTS FROM PRIMARY RESEARCH
25. REPORT CONCLUSION
26. TABULATED DATA
27. LIST OF COMPANIES AND ORGANIZATIONS
For more information about this report visit https://www.researchandmarkets.com/r/4rgeqd
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.